Autoimmune Market Research Reports & Industry Analysis
Classification of autoimmune disorders is still somewhat controversial, but the following criteria is generally accepted: Direct evidence from transfer of pathogenic antibody or pathogenic T cells, indirect evidence based on reproduction of the autoimmune disease in experimental animals, and circumstantial evidence from clinical clues
Arthritis is among the most common autoimmune disorders. Arthritis is joint inflammation The major complaint by individuals who have arthritis is joint pain. Pain is often a constant and may be localized to the joint affected. There are over one hundred forms different forms The most common form, osteoarthritis (degenerative joint disease) is a result of trauma to the joint, infection of the joint, or age. Other arthritis forms are rheumatoid arthritis, psoriatic arthritis, and related autoimmune diseases. Septic arthritis is caused by joint infection. Treatment options vary depending on the type of arthritis and include physical therapy, exercise and weight control, bracing, medications. Surgery may be required in some changes.
Autoimmune Industry Research & Market Reports
-
Primary Sjogren's Syndrome - Global Clinical Trials Review, 2024
... of Primary Sjogren's Syndrome Clinical trials scenario. This report provides top line data relating to the clinical trials on Primary Sjogren's Syndrome. Report includes an overview of trial numbers and their average enrollment in top ... Read More
-
Global Autoimmune Hemolytic Anemia Therapeutics Market 2024-2028
... on the autoimmune hemolytic anemia therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis ... Read More
-
Global Celiac Diseases Drugs Market 2024-2028
... celiac diseases drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current ... Read More
-
Epidermal Growth Factors (EGFs) Market (Type of EGFs: TGF-alpha, Amphiregulin, Epiregulin, Betacellulin, and Others, and Application: Skincare Products, Wound Healing, cancer Therapy, Autoimmune Disorders, Regenerative Medicine, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034
... Trends, and Forecast, 2024-2034 Epidermal Growth Factors (EGFs) Market – Scope of Report TMR’s report on the global epidermal growth factors (EGFs) market studies the past as well as the current growth trends and opportunities ... Read More
-
Hydroxychloroquine Market Size, Trends, Analysis, and Outlook By Product (Tablet, Active Pharmaceutical Ingredients), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Specialty Drug Store), By Disease (Malaria, Rheumatoid Arthritis, Lupus Erythematosus, Coronavirus, Others), by Country, Segment, and Companies, 2024-2030
... Country, Segment, and Companies, 2024-2030 The global Hydroxychloroquine market size is poised to register a 7.2% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The Hydroxychloroquine market study ... Read More
-
Cutaneous Lupus Erythematosus Market by Clinical Presentation (Acute Cutaneous Lupus Erythematosus, Chronic Cutaneous Lupus Erythematosus, Subacute Cutaneous Lupus Erythematosus), Drug Class (Antimalarial Drugs, Corticosteroids, Immunosuppressants), Route
... USD 2.07 billion in 2023 and expected to reach USD 2.26 billion in 2024, at a CAGR 9.72% to reach USD 3.96 billion by 2030. Cutaneous lupus erythematosus (CLE) is a kind of lupus that ... Read More
-
Human Microbiome Market by Disease (Acute Diarrhea, Autoimmune Disorders, Cancer), Technology (16s rRNA Sequencing, Cell Culture Technology, Computational Tools), Product, Therapeutic Area, Application - Global Forecast 2024-2030
... USD 1.58 billion in 2023 and expected to reach USD 1.96 billion in 2024, at a CAGR 23.90% to reach USD 7.11 billion by 2030. The human microbiome is the collective genomes of the microorganisms ... Read More
-
RNA Interference Technology Market by Type (dsRNA, miRNA, siRNA), Therapeutics (Autoimmune Hepatitis, Hepatitis B and C, Neurological Disorders), Application - Global Forecast 2024-2030
... in 2023 and expected to reach USD 39.25 billion in 2024, at a CAGR 22.38% to reach USD 135.40 billion by 2030. The RNA interference (RNAi) technology market encompasses systems that use small RNA molecules ... Read More
-
Custom Antibody Market by Service (Development, Purification, Fragmentation, Labeling), Type (mAbs, pAbs, rAbs), Source (Rabbit, Mice), Application (Research, Therapeutics), Indication (Oncology, Immunology, Infectious, CVD) - Global Forecast to 2029
... to reach USD 901 million in 2029 from USD 579 million in 2024, at a CAGR of 9.2% during the forecast period. The growth of this market can be attributed to the increasing prevalence of ... Read More
-
Esoteric Testing Market Size, Share & Trends by Type (Endocrinology, Oncology, Neurology, Genetic Tests, Autoimmune, Infectious Diseases), Technology (ELISA, CLIA, Flow Cytometry, NGS, RT-PCR, Chromatography, Spectrometry), Specimen (Blood, Urine) - Global Forecast to 2029
... global esoteric testing market is valued at an estimated USD 32.2 billion in 2024 and is projected to reach USD 48.3 billion by 2029, at a CAGR of 8.5% during the forecast period. Growth in ... Read More
-
Autoimmune Hepatitis – Market Insight, Epidemiology, and Market Forecast – 2034
... epidemiology as well as the Autoimmune Hepatitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Autoimmune Hepatitis market report provides current treatment practices, emerging drugs, Autoimmune ... Read More
-
Global Kinase Inhibitor in Autoimmune Diseases – Market Insight, Epidemiology, and Market Forecast – 2034
... understanding of the Global Kinase Inhibitor in Autoimmune Diseases, historical and forecasted epidemiology as well as the Global Kinase Inhibitor in Autoimmune Diseases market trends in the United States, EU5 (Germany, Spain, Italy, France, and ... Read More
-
Autoimmune Encephalitis – Market Insight, Epidemiology, and Market Forecast – 2034
... epidemiology as well as the Autoimmune Encephalitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Autoimmune Encephalitis market report provides current treatment practices, emerging drugs, Autoimmune ... Read More
-
Palmoplantar Pustulosis (PPP) – Market Insight, Epidemiology, and Market Forecast – 2034
... historical and forecasted epidemiology as well as the Palmoplantar Pustulosis (PPP) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Palmoplantar Pustulosis (PPP) market report provides current ... Read More
-
Autoimmune gastritis – Market Insight, Epidemiology, and Market Forecast – 2034
... epidemiology as well as the Autoimmune gastritis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Autoimmune gastritis market report provides current treatment practices, emerging drugs, Autoimmune ... Read More
-
Allogeneic T-cell therapy for autoimmune diseases – Market Insight, Epidemiology, and Market Forecast – 2034
... understanding of the Allogeneic T-cell therapy for autoimmune diseases, historical and forecasted epidemiology as well as the Allogeneic T-cell therapy for autoimmune diseases market trends in the United States, EU5 (Germany, Spain, Italy, France, and ... Read More
-
Liver Disease Therapeutic Market Report by Therapy Type (Anti-Rejection Drugs/Immunosuppressants, Chemotherapy Drugs, Targeted therapy, Vaccines, Immunoglobulins, Corticosteroids, and Anti-Viral Drugs) Disease Type (Non-alcoholic Fatty Liver Disease (NAFLD), Viral Hepatitis (B, C, D), Alcoholic Liver Disease (ALD), and Autoimmune Liver Disease (ALD)) End Users (Hospitals, Laboratories, and Others) Regions and Company Analysis 2024-2032
... (ALD), and Autoimmune Liver Disease (ALD)) End Users (Hospitals, Laboratories, and Others) Regions and Company Analysis 2024-2032 The market for Liver Disease Therapeutics is predicted to reach US$ 28.98 billion in 2032, increasing at a ... Read More
-
Antiphospholipid Syndrome (APS) – Market Insight, Epidemiology, and Market Forecast – 2034
... historical and forecasted epidemiology as well as the Antiphospholipid Syndrome (APS) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Antiphospholipid Syndrome (APS) market report provides current ... Read More
-
Adult-onset Still Disease – Market Insight, Epidemiology, and Market Forecast – 2034
... historical and forecasted epidemiology as well as the Adult-onset Still Disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Adult-onset Still Disease market report provides current ... Read More
-
Eczema – Market Insight, Epidemiology, and Market Forecast – 2034
... as the Eczema market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Eczema market report provides current treatment practices, emerging drugs, Eczema market share of the individual ... Read More
-
Global Human Microbiome Market Report by Application (Therapeutics, Diagnostics) Disease (Obesity, Diabetes, Autoimmune Disorders, Cancer, Gastrointestinal Disorders, Central Nervous System Disorders, Other Diseases) Product (Probiotics, Prebiotics, Symboitics, Other Products), Countries and Company Analysis, 2024-2032
... Human Microbiome Market will grow US$ 3.05 Billion by 2032 from US$ 0.72 Billion in 2023, with a CAGR of 17.48% during 2023-2032. The human microbiome is a collection of microorganisms found on and within ... Read More
-
Autoimmune Uveitis – Market Insight, Epidemiology, and Market Forecast – 2034
... epidemiology as well as the Autoimmune Uveitis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Autoimmune Uveitis market report provides current treatment practices, emerging drugs, Autoimmune ... Read More
-
Stem Cell Therapy Market, By Cell Source (Adult Stem Cells, Induced Pluripotent Stem Cells, Embryonic Stem Cells, Others), By Application (Musculoskeletal Disorders, Wounds and Injuries, Cancer, Autoimmune Disorders, Others), By End User (Hospitals, Cell Banks , Academic and Research Institutes), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... , Academic and Research Institutes), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) Stem cell therapy is a promising and emerging field in regenerative medicine that involves the use of ... Read More
-
Global Autoimmune Disease Treatment Market Professional Survey by Types, Applications, and Players, with Regional Growth Rate Analysis and Development Situation, from 2023 to 2028
... growth of the Autoimmune Disease Treatment industry between the year 2018 to 2028, and breaks down according to the product type, downstream application, and consumption area of Autoimmune Disease Treatment. The report also introduces players ... Read More
-
Global Immunoglobulin Products Market 2024-2028
... market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the ... Read More
Research Assistance
